TotalMarketCap

Cue Biopharma

CUENasdaq United StatesHealth CareBiotechnology: Pharmaceutical Preparations

Market cap

$128.907 M

$17.75 -10.56%

Close of 6 Nov 2026

As of 6 Nov 2026, Cue Biopharma (CUE) has a market capitalization of $128.9M. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

$27.5M

#2886 by revenue

Earnings

-$26.6M

Loss-making

Shares outstanding

7,264,414

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 498 →
  1. #272Organigram GlobalOGI$132.3M
  2. #273Jyong BiotechMENS$129.2M
  3. #274Cue BiopharmaCUE$128.9M
  4. #275Yarrow BioscienceYARW$126.1M
  5. #276PDS BiotechnologyPDSB$123.9M

What if Cue Biopharma were worth as much as…

Open the what-if tool →

Gold $28.2T

$3,887,013

Per share 219,048× higher

Bitcoin $1.53T

$210,319.52

Per share 11,852× higher

Apple $5.02T

$690,459.36

Per share 38,910× higher

Or at a round number

$200.0M$500.0M$1.00B$2.00B

Where these numbers come from

Share counts and financials for Cue Biopharma are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.